{
    "id": 29630,
    "fullName": "SUV39H2 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "SUV39H2 positive indicates the presence of the SUV39H2 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 79723,
        "geneSymbol": "SUV39H2",
        "terms": [
            "SUV39H2",
            "KMT1B"
        ]
    },
    "variant": "positive",
    "createDate": "03/28/2019",
    "updateDate": "11/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16626,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, OTS193320 and Adriamycin (doxorubicin) had an additive effect on tumor growth inhibition in SUV39H2-positive lung cancer cell line xenograft models (PMID: 30159125).",
            "molecularProfile": {
                "id": 31712,
                "profileName": "SUV39H2 positive"
            },
            "therapy": {
                "id": 8110,
                "therapyName": "Doxorubicin + OTS193320",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 14641,
                    "pubMedId": 30159125,
                    "title": "Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30159125"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16624,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, OTS193320 inhibited growth of a SUV39H2-expressing lung cancer cell line in culture, and inhibited tumor growth in xenograft models (PMID: 30159125).",
            "molecularProfile": {
                "id": 31712,
                "profileName": "SUV39H2 positive"
            },
            "therapy": {
                "id": 8109,
                "therapyName": "OTS193320",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 14641,
                    "pubMedId": 30159125,
                    "title": "Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30159125"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31712,
            "profileName": "SUV39H2 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}